| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 02/23/2005 | CN1584021A Collecting method for insect virus breed |
| 02/23/2005 | CN1582651A Hybrid breeding method for sea cucumber |
| 02/23/2005 | CN1582650A Hybrid method of Afria crucia carp and mandarin fish |
| 02/23/2005 | CN1190127C Device for industrial production of biomaggot |
| 02/23/2005 | CN1190125C Automatic testing method and system for chicken sex |
| 02/22/2005 | US6858773 Transgenic rodents for use in the diagnosis and treatment of parasitic infections, asthma, rhinitis, inflammation and dermatitis |
| 02/22/2005 | US6858586 Pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation |
| 02/22/2005 | US6858420 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/17/2005 | WO2005015161A2 Imaging regulated protein-protein interactions in cells and living animals by enhanced luciferase protein fragment complementation |
| 02/17/2005 | WO2005014022A1 Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 02/17/2005 | WO2005013889A2 Truncated fragments of alpha-synuclein in lewy body disease |
| 02/17/2005 | WO2005013682A2 Animal model for the analysis of tumor metastasis |
| 02/17/2005 | WO2005013681A1 Procedure of genetic recombination for galinaceae hybrids breeding |
| 02/17/2005 | WO2005013680A1 Method for producing avian chimera using spermatogonial cells and avian chimera |
| 02/17/2005 | WO2005013679A1 Reproductive and non-reproductive cloning method |
| 02/17/2005 | WO2004089072A8 Non-human mammals and animal cells containing a mutated alpha2/delta1 gene |
| 02/17/2005 | WO2004081189A9 Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and organisms |
| 02/17/2005 | US20050039223 Knock-in-mouse |
| 02/17/2005 | US20050039222 Sgrf gene-modified non-human animals |
| 02/17/2005 | US20050039221 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 02/17/2005 | US20050039220 Labeled coronavirus protein for use as diagnostic tool in detection of viral infection; viricides and vaccine development for treatment and prevention of respiratory system disorders |
| 02/17/2005 | US20050037971 Use of hepcidin as a regulator of iron homeostasis |
| 02/17/2005 | US20050037961 Generation, maintenance vascular system tissue; controlling gene expression; cardiovascular disorders |
| 02/17/2005 | CA2532759A1 Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases |
| 02/17/2005 | CA2531916A1 Animal model for the analysis of tumor metastasis |
| 02/17/2005 | CA2526900A1 Truncated fragments of alpha-synuclein in lewy body disease |
| 02/17/2005 | CA2526274A1 Prostate stem cell antigen (psca) variants and subsequences thereof |
| 02/16/2005 | EP1506317A2 Marker molecules associated with lung tumors |
| 02/16/2005 | EP1506316A1 Method for improving efficiencies in livestock production |
| 02/16/2005 | EP1506227A1 Methods for identifying and developing compounds that interact with voltage-gated potassium channels of the kv4 family |
| 02/16/2005 | EP1505870A1 Method and device for injecting at least one product in an egg for treating the embryo |
| 02/16/2005 | EP1373473A4 Gene targeting methods and vectors |
| 02/16/2005 | EP1292184B1 New screening tool for analyzing the behavior of laboratory animals |
| 02/16/2005 | EP1102531B1 Method and device for rearing fly larvae for therapeutic application |
| 02/16/2005 | CN2678359Y Factorial and mass breedable insect box suitable for single breeding of insect |
| 02/16/2005 | CN1582332A GFP-transfected clon pig, GT knoc-out clon pig and methos for production thereof |
| 02/16/2005 | CN1582165A Antibodies to CD40 |
| 02/16/2005 | CN1580266A Method for extablishing polymorphism adenoid tumour mouse model |
| 02/16/2005 | CN1580251A Method for efficiently establishing pure line gene knock-out mouse model |
| 02/16/2005 | CN1580249A Method for screening and establishing mouse-development-related gene mutation ES cell bank |
| 02/16/2005 | CN1579196A Engineered fly biological high-protein powder |
| 02/16/2005 | CN1189076C Process for screening anti type-C hepatitis virus medicines |
| 02/15/2005 | US6855365 Recombinant bacterial phytases and uses thereof |
| 02/15/2005 | US6855321 Polyepitope carrier protein |
| 02/10/2005 | WO2005012517A2 Use of the fret phenomenon for in vivo follow-up of biological events |
| 02/10/2005 | WO2005011371A1 Method of constructing nuclear-transplanted egg, parthenogenetic embryo and parthenogenetic mammal |
| 02/10/2005 | WO2004078916A3 In vitro micro-organs, and uses related thereto |
| 02/10/2005 | WO2004062591A3 Methods of treatment and diagnosis of kaposi's sarcoma (ks) and ks related diseases |
| 02/10/2005 | WO2002064626A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 02/10/2005 | US20050034186 Site specific nucleic acid integration |
| 02/10/2005 | US20050034185 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 02/10/2005 | US20050034183 Non-human animal model for analysis of the original and therapy of organ fibrosis |
| 02/10/2005 | US20050034182 Transgenic mouse with genome DNA sequence encoding a mutated human tau protein linked to promoter; mouse brain exhibits neurofibrillary tangles; Alzheimer*s and neurodegenerative disease |
| 02/10/2005 | US20050034181 Unactivated oocytes as cytoplast recipients for nuclear transfer |
| 02/10/2005 | US20050034179 Transgenic animal cell which express tumor necrosis factor receptor for use in identifying agents for treatment of diabetes and inflammatory bowel disease |
| 02/10/2005 | US20050034177 Genetic modification of male germ cells for generation of transgenic species & genetic therapies |
| 02/10/2005 | US20050034175 Immune cloning and uses thereof |
| 02/10/2005 | US20050033042 Nucleic acids encoding recominant 56 and 82 kda antigens fromn gametocytes of eimeria maxima and their uses |
| 02/10/2005 | US20050032223 Generating site directed DNA breaks in transformed cells via expression of heterologous endonuclease; bioreactor for generating exogenous proteins; gene therapy |
| 02/10/2005 | US20050032170 Expression vector comprising nucleotide sequences coding native sequence-4 (NS4) for use in identifying modulators for treatment and prevention of obesity, cachexia and anorexia |
| 02/10/2005 | US20050032155 Expression vector comprising nucleotide sequences coding defective receptor protein for use as model in treatment and prevention of convulsive disorders |
| 02/10/2005 | US20050032085 Novel chromophores/fluorophores and methods for using the same |
| 02/10/2005 | CA2533613A1 Method for the production of multiply-unsaturated fatty acids in transgenic organisms |
| 02/09/2005 | EP1505152A1 EXPRESSION SYSTEMS FOR STEM LOOP RNA MOLECULE HAVING RNAi EFFECT |
| 02/09/2005 | EP1504092A2 Methods and compositions for using zinc finger endonucleases to enhance homologous recombination |
| 02/09/2005 | EP1456223A4 Rapidly maturing fluorescent proteins and methods for using the same |
| 02/09/2005 | EP1313885A4 Methods of using agents that modulate bone formation and inhibit adipogenesis |
| 02/09/2005 | EP1017805B1 Men1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides, and uses thereof |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/09/2005 | CN1188031C Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 02/08/2005 | US6852906 Monitoring enzyme activity in cells; obtain cells, incubate with labeled substrate, detect adjustment in physical properties of cell, adjustment in physical property indicates enzyme activity |
| 02/08/2005 | US6852518 Glycosyl sulfotransferases GST-4α, GST-4β, and GST-6 |
| 02/08/2005 | CA2323726C Control of gene expression |
| 02/03/2005 | WO2005010165A2 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 02/03/2005 | WO2005010039A1 Bsep polypeptide variants and uses thereof |
| 02/03/2005 | WO2005009134A1 ACELLULAR TISSUE MATRICES MADE FROM GALACTOSE α-1,3-GALACTOSE-DEFICIENT TISSUE |
| 02/03/2005 | WO2005009119A1 Rat model of diabetic nephropathy |
| 02/03/2005 | WO2004102195A8 Method for identifying tff2 regulating agents and agents identified using said method |
| 02/03/2005 | WO2004100773A3 Diagnostic and therapeutic treatments related to mitochondrial disorders |
| 02/03/2005 | WO2004094594A3 Non-human animal model for graft-versus-host disease |
| 02/03/2005 | WO2003064606A3 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 02/03/2005 | US20050028229 Alpha-hemoglobin stabilizing protein transgenic mouse and methods of use thereof |
| 02/03/2005 | US20050028228 Acellular tissue matrices made from alpa-1,3-galactose-deficient tissue |
| 02/03/2005 | US20050028227 Bile salt export pump (BSEP); antibodies; gene expression inhibition; drug screening; high throughput assay; host cells |
| 02/03/2005 | US20050026838 Fibroblast Growth Factor-13 |
| 02/03/2005 | US20050026292 GLYT1 conditional knock-out mice |
| 02/03/2005 | US20050026278 RNA interference mediating small RNA molecules |
| 02/03/2005 | US20050026252 Expression vector comprising rodent regulatory sequences for use as gene expression control tools in genetic engineering |
| 02/03/2005 | US20050026251 Netrin receptor protein for use in identification of modulator for use in treatment and prevention of infection, nervous system, autoimmune, inflammatory, psycological and reproductive disorders |
| 02/03/2005 | US20050026246 Method for generating diversity |
| 02/03/2005 | US20050025753 Methods for production of non-disease causing hemoglobin by ex vivo oligonucleotide gene editing of human stem/progenitor cells |
| 02/03/2005 | CA2533315A1 Rat model of diabetic nephropathy |
| 02/03/2005 | CA2533259A1 Acellular tissue matrices made from galactose .alpha.-1,3-galactose-deficient tissue |
| 02/03/2005 | CA2526814A1 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 02/02/2005 | EP1502920A2 Cell surface molecule mediating cell adhesion and signal transmission |
| 02/02/2005 | EP1501946A2 Diagnostic and therapeutic use of a golgi protein for neurodegenerative diseases |
| 02/02/2005 | EP1501923A2 Pak5-related compositions and methods |
| 02/02/2005 | EP1501863A2 Kinase anchor protein muteins, peptides thereof, and related methods |
| 02/02/2005 | EP1501857A2 Novel pancortin-pablo protein interactions and methods of use thereof |
| 02/02/2005 | EP1501465A2 Vectors having both isoforms of beta-hexosaminidase |